Artelo Biosciences Stock Price - ARTL

1.28
-0.03 (-2.29%)
Upgrade to Real-Time
Afterhours (Closed)
1.31
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Artelo Biosciences Inc ARTL NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.05 3.97% 1.31 1.26 1.33 1.33 1.26 00:00:03
Bid Price Ask Price Spread Spread % News
1.27 1.46 0.19 13.01% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
516 120,187 $ 1.30 $ 155,961 218,968 0.61 - 5.00
Last Trade Time Type Quantity Stock Price Currency
17:42:10 formt 218 $ 1.28 USD

Artelo Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.49M 3.43M 2.78M $ - $ - -1.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 4.00 27.10%

more financials information »

Artelo Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.371.751.141.50762,506-0.06-4.38%
1 Month1.331.751.031.43303,372-0.02-1.5%
3 Months0.862.050.611.29224,8610.4552.33%
6 Months2.344.42340.611.94222,571-1.03-44.02%
1 Year4.955.000.612.06132,669-3.64-73.54%
3 Years4.955.000.612.06132,669-3.64-73.54%
5 Years4.955.000.612.06132,669-3.64-73.54%

Artelo Biosciences Description

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.


Your Recent History
NASDAQ
ARTL
Artelo Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.